ANTONELLI, ANTONELLA
 Distribuzione geografica
Continente #
NA - Nord America 7.916
EU - Europa 5.128
AS - Asia 3.427
SA - Sud America 401
AF - Africa 49
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 19
AN - Antartide 1
Totale 16.962
Nazione #
US - Stati Uniti d'America 7.822
GB - Regno Unito 1.841
CN - Cina 1.746
SG - Singapore 937
UA - Ucraina 793
IT - Italia 596
SE - Svezia 442
RU - Federazione Russa 366
FI - Finlandia 323
TR - Turchia 321
BR - Brasile 317
DE - Germania 313
IE - Irlanda 192
VN - Vietnam 155
FR - Francia 84
IN - India 62
JP - Giappone 59
CA - Canada 49
PL - Polonia 46
BE - Belgio 40
MX - Messico 36
AR - Argentina 35
KR - Corea 27
BD - Bangladesh 25
IR - Iran 20
AU - Australia 19
NL - Olanda 19
ZA - Sudafrica 19
EU - Europa 15
RO - Romania 12
ES - Italia 11
LT - Lituania 11
AT - Austria 10
EC - Ecuador 10
IQ - Iraq 10
MA - Marocco 10
ID - Indonesia 9
TG - Togo 9
CL - Cile 8
PY - Paraguay 8
AZ - Azerbaigian 6
CO - Colombia 6
HK - Hong Kong 6
IL - Israele 5
LA - Repubblica Popolare Democratica del Laos 5
PE - Perù 5
PK - Pakistan 5
TW - Taiwan 5
VE - Venezuela 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AE - Emirati Arabi Uniti 4
CR - Costa Rica 4
NO - Norvegia 4
SA - Arabia Saudita 4
SK - Slovacchia (Repubblica Slovacca) 4
JM - Giamaica 3
JO - Giordania 3
KE - Kenya 3
MD - Moldavia 3
NG - Nigeria 3
PH - Filippine 3
PT - Portogallo 3
AL - Albania 2
BG - Bulgaria 2
BO - Bolivia 2
CZ - Repubblica Ceca 2
EE - Estonia 2
EG - Egitto 2
GY - Guiana 2
HN - Honduras 2
KZ - Kazakistan 2
NZ - Nuova Zelanda 2
UY - Uruguay 2
AM - Armenia 1
AQ - Antartide 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CY - Cipro 1
DK - Danimarca 1
DZ - Algeria 1
ET - Etiopia 1
FK - Isole Falkland (Malvinas) 1
GE - Georgia 1
HR - Croazia 1
HU - Ungheria 1
IS - Islanda 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LV - Lettonia 1
MY - Malesia 1
QA - Qatar 1
RS - Serbia 1
UZ - Uzbekistan 1
Totale 16.962
Città #
Southend 1.688
Fairfield 867
Woodbridge 786
Ashburn 681
Jacksonville 632
Houston 603
Ann Arbor 493
Chandler 473
Nanjing 380
Cambridge 368
Singapore 349
Seattle 345
Wilmington 333
Izmir 237
Dallas 232
Urbino 220
Beijing 217
Dublin 188
Boardman 178
Nanchang 157
Helsinki 134
New York 130
Los Angeles 117
Princeton 103
San Mateo 94
Changsha 77
Moscow 70
Bremen 67
Hebei 63
Tianjin 62
Shenyang 60
Buffalo 57
Munich 55
Düsseldorf 53
Ho Chi Minh City 49
Kunming 43
Istanbul 42
Jiaxing 42
Brussels 40
Shanghai 39
Santa Clara 37
Guangzhou 33
Hanoi 33
São Paulo 31
Jinan 30
London 30
San Diego 28
Velikiy Novgorod 27
Hangzhou 24
Tokyo 23
Turku 23
Zhengzhou 23
Warsaw 22
Frankfurt am Main 21
Toronto 21
Stockholm 20
Chicago 19
San Francisco 19
Brooklyn 17
Mülheim 17
Lauterbourg 15
Ningbo 14
Boston 13
Council Bluffs 13
Denver 13
Kraków 13
Mexico City 13
Orem 13
Poplar 13
Rio de Janeiro 13
Rome 13
Seongnam 13
Atlanta 12
Des Moines 12
Lanzhou 12
Norwalk 12
Shenzhen 12
Johannesburg 11
Nuremberg 11
Portsmouth 11
Seoul 11
Auburn Hills 10
Augusta 10
Leawood 10
Taizhou 10
Chennai 9
Hamburg 9
Lomé 9
Portland 9
Turin 9
Amsterdam 8
Montreal 8
Phoenix 8
Redwood City 8
Ankara 7
Campinas 7
Da Nang 7
Milan 7
Mumbai 7
Vienna 7
Totale 11.744
Nome #
Interactions of Nitroxide-Conjugated and non-Conjugated Glycodendrimers with Normal and Cancer Cells and Biocompatibility Studies 287
Engineering erythrocytes for the modulation of drugs' and contrasting agents' pharmacokinetics and biodistribution 271
Dexamethasone restrains ongoing expression of interleukin-23p19 in peripheral blood-derived human macrophages. 267
2\',3\'-Dideoxycytidine cytotoxicity in human macrophages. 249
Effect of macrophage depletion on viral DNA rebound following antiretroviral therapy in a murine model of AIDS (MAIDS) 247
Effect of the redox state on HIV-1 tat protein multimerization and cell internalization and trafficking 244
Macrophage Depletion by Free Bisphosphonates and Zoledronate-Loaded Red Blood Cells 240
Improved cellular uptake of functionalized single-walled carbon nanotubes 239
Erythrocyte-based drug delivery 236
2',3'-Dideoxycytidine induced drug-resistance in human cells 234
Drug delivery through phagocytosis of red blood cells 233
Red Blood Cell-Based Delivery of Drugs and Nanomaterials for Therapeutic and Diagnostic Applications 232
Intracellular distribution of hexokinase in rabbit brain 228
Characterization of ferucarbotran-loaded RBCs as long circulating magnetic contrast agents 228
Effect of the redox state on HIV-1 tat protein multimerization and cell internalization and trafficking 226
Efficient inhibition of macrophage TNF-alpha production upon targeted delivery of K48R ubiquitin 218
Programmable 3D silk bone marrow niche for platelet generation ex vivo and modeling of megakaryopoiesis pathologies 210
Macrophage depletion induced by clodronate-loaded erythrocytes. 208
Encapsulation of superparamagnetic nanoparticles into red blood cells as new carriers of MRI contrast agents 205
New strategies to prolong the in vivo life span of iron-based contrast agents for MRI 199
Delivery of Contrasting Agents for Magnetic Resonance Imaging 198
Red blood cells as glucocorticoids delivery system. 196
Human erythrocytes as nanoparticle carriers for Magnetic Particle Imaging 196
New biomimetic constructs for improved in vivo circulation of superparamagnetic nanoparticles 196
SPIO nanoparticles encapsulation into human erythrocytes for MPI application 191
Dexamethasone restrains ongoing expression of interleukin-23p19 in periferal blood-derived human macrophages. 191
The ubiquitin-dependent proteolytic system and other potential targets for the modulation of nuclear factor-kB (NF-kB) 189
Intravascular contrast agents in diagnostic applications: Use of red blood cells to improve the lifespan and efficacy of blood pool contrast agents 188
Macrophage protection by nucleoside and nucleotide analogue administration 185
SPIO NANOPARTICLES ENCAPSULATION INTO HUMAN ERYTHROCYTES FOR MPI APPLICATION 184
A Relaxometric Study of USPIO-loaded Red Blood Cells as MRI Contrast Agents 184
Erythrocyte-based drug delivery 182
Modulation of ICAM-1 expression in ECV304 cells by macrophage-released cytokines 181
Characterization and biological activity of the main flavonoids from Swiss Chard (Beta vulgaris subspecies cycla) 177
Erythrocyte-mediated delivery of drugs, peptides and modified oligonucleotides 176
USPIO-loaded Red Blood Cells as a biomimetic MR contrast agent: a relaxometric study 176
Red blood cell phagocytosis following hexokinase inactivation. 175
Red blood cells as carriers in magnetic particle imaging 175
Increased microbicidal activity of human monoblastoid cells upon long-term exposure to dideoxycytidine 174
Red blood cells as a glucocorticoids delivery system 173
The soluble but not mitochondrially bound hexokinase is a substrate for the ATP- and ubiquitin-dependent proteolytic system 171
A proteomic approach to identify ubiquitinated proteins in a macrophage cell-free system 169
Targeting dexamethasone to macrophages. 168
Drug-loaded red blood cells for the control of the inflammatory response: selective targeting of nuclear factor-kB (NF-kB) 168
Encapsulation of new ferucarbotran nanoparticles into red blood cells as potential MPI contrast agent 168
Effect of macrophage depletion on viral DNA rebound following antiretroviral therapy in a murine model of AIDS 167
Development of long circulating magnetic particle imaging tracers: use of novel magnetic nanoparticles and entrapment into human erythrocytes 166
Modulation of NF-kB activation by targeted delivery of dexamethasone to macrophages 161
Nanoparticle encapsulation in red blood cells enables blood-pool magnetic particle imaging hours after injection 161
Macrophage uptake of SWNT-COOC18H37 derivatives coated by phosphatidylethanolamine or phosphatidylserine 158
Macrophage protection by nucleoside and nucleotide analogue administration 158
Bone marrow modeling for blood cell production 155
Red Blood Cells as Magnetic Carriers for MPI Applications 152
Red Blood Cells as Carriers of Iron Oxide-Based Contrast Agents for Diagnostic Applications 152
In vivo survival and in vitro phagocytosis of engineered erythrocytes. 149
Macrophage depletion by Clodronate-loaded erythrocytes 149
Molecular basis of the 2',3'-dideoxycytidine induced drug-resistance in human cells 147
Hexokinase is not ubiquitaned when mitochondrial-bound 146
Study on the in vivo survival of murine Ferucarbotran-loaded RBCs for their use as new MPI contrast agents 146
Single-Walled Carbon Nanotubes Functionalization for the Delivery of the Water Insoluble Anticancer Agent Indole-3-carbinol Cyclic Tetrameric Derivative CTet 145
Use of Red Blood Cells as New Strategy to Avoid the Rapid Clearance of SPIOs Nanoparticles 144
Erythrocytes as vascular carriers of superparamagnetic nanoparticle contrast agents 143
Recent advances in synthesis, characterization of hydroxyapatite/polyurethane composites and study of their biocompatible properties 143
Selective inhibition of NF-kB activation and TNF-alpha production in macrophages by red blood cell-mediated delivery of dexamethasone 143
Macrophages depletion induced by clodronate-loaded erythrocytes 141
New biomimetic constructs for improved in vivo circulation of superparamagnetic nanoparticles 141
Effect of the redox state on HIV-1 tat protein multimerization and cell internalization and trafficking 141
Location of ubiquitin conjugates and ubiquitin-conjugating enzymes in rabbit brain 139
Biological Activity of Phytocomplexes purified from Beta Vulgaris 138
Ferucarbotran-loaded red blood cells as long circulating MRI contrast agents: first in vivo results in mice 136
Antiviral Properties of Flavonoids and Delivery Strategies 135
Magnetic red blood cells as new contrast agents for MRI applications 126
Magnetic Manipulation of Blood Conductivity with Superparamagnetic Iron Oxide-Labeled Erythrocytes 126
In vivo nanotoxicology: experiences in NACBO project 123
Encapsulation of Magnetic Nanoparticles in Human Erythrocytes 121
In vitro survival and in vitro phagocytosis of engineered erythrocytes. 119
Evidence for a particulate location of ubiquitin conjugates and ubiquitin-conjugating enzymes in rabbit brain. 115
Use of Red Blood Cells to prolong the in vivo life span of Iron-based contrast agents for MRI and MPI 115
Programmed cell death in 2',3'-dideoxycytidine-resistant human monoblastoid U937 cells. 115
Human Red Blood Cells Modulate Cytokine Expression in Monocytes/Macrophages Under Anoxic Conditions 114
Efficient inhibition of macrophage TNF-alpha production by red cell mediated drug targeting 113
New biomimetic contructs for improved in vivo circulation of superparamagnetic nanoparticles. 113
Modulation of the macrophage function in the hematopoietic niche by using engineered RBCs 112
11. RED BLOOD CELLS AS A GLUCOCORTICOIDS DELIVERY SYSTEM 112
Engineered Red Blood Cells for the delivery and targeting of corticosteroid analogues 111
Modulation of macrophage activation by red cell-mediated drug targeting 111
New biomimetic constructs to prolong in vivo the life span of iron-based MRI/MPI contrasting agents 110
Red Blood Cells Constructs to Prolong the Life Span of Iron-Based Magnetic Resonance Imaging/Magnetic Particle Imaging Contrast Agents In Vivo 109
Evaluation of magnetization response of superparamagnetic nanoparticles loaded RBCs 108
In vivo survival and in vitro phagocytosis of engeneered erythrocytes 107
Specific targeting of antisense PNA by erythrocytes for the inhibition of nitric oxide production in murine macrophages 105
Red blood cells for improved in vivo circulation of SPIO nanoparticles MRI contrast agents 100
Characterization of the Synomag®-D-PEG-OMe nanoparticles for the encapsulation in human and murine red blood cells 97
Anoxia Rapidly Induces Changes in Expression of a Large and Diverse Set of Genes in Endothelial Cells 97
Inhibition of nitric oxide production in murine macrophages by specific targeting of antisense PNA loaded erythrocytes 92
The influence of redox modulation on hypoxic endothelial cell metabolic and proteomic profiles through a small thiol-based compound tuning glutathione and thioredoxin systems 91
Encapsulation in human and murine erythrocytes of the Synomag®-D-PEG-OMe tracer for MPI application 89
Encapsulation of new MPI tracer nanoparticles in the human red blood cells 86
Modulation of ICAM-1 expression in ECV304 cells by macrophage conditioned medium 84
Encapsulation of new MPI tracer nanoparticles in the human red blood cells 78
Totale 16.187
Categoria #
all - tutte 61.965
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.965


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.012 0 0 0 0 0 111 92 107 187 168 266 81
2021/20221.077 71 88 126 124 41 47 93 70 66 84 23 244
2022/20231.603 204 88 29 160 182 340 3 86 316 59 84 52
2023/2024451 49 36 32 60 45 105 12 20 7 38 5 42
2024/20251.959 96 70 345 151 76 130 219 97 252 158 207 158
2025/20262.579 404 393 487 838 438 19 0 0 0 0 0 0
Totale 17.166